These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4344874)

  • 1. [ 131 I-labelled tumor-specific antibodies: trial to concentrate radioisotopes specifically in the tumor. I. Binding of anti-mouse hepatoma antibody to the tumor].
    Makidono R; Watanabe K; Terashima H; Matsuura K; Nomoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1972 Aug; 32(5):412-24. PubMed ID: 4344874
    [No Abstract]   [Full Text] [Related]  

  • 2. [131I-labelled tumor-specific antibodies: a trials to concentrate radioisotoopes specifically in the tumor. II. The binding of 131I-labelled anti-human alpha-fetoprotein antibody to the cultured human hepatoma cells].
    Makidono R; Watanabe K; Terashima H; Matsuura K; Nomoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1973 May; 33(5):418-20. PubMed ID: 4359483
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences between antibodies against the dense sediment and microsome fractions of the N-2-fluorenylacetamide-induced rat hepatoma.
    Isojima S; Bernecky J; Planinsek J; Yagi Y; Pressman D
    Cancer Res; 1965 Aug; 25(7):968-75. PubMed ID: 4284751
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytotoxic antibodies against tumor cells in the blood of intact C3H mice].
    LavrovskiÄ­ VA; Viksler VKh; Ustinov AS
    Biull Eksp Biol Med; 1979 May; 87(5):460-2. PubMed ID: 222378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the immunological response to hepatoma XXII in the inbred SZNA mice].
    Basmidzhian ME; Aleksanian IuT; Tat'ian MB
    Zh Eksp Klin Med; 1974; 14(5):19-21. PubMed ID: 4376644
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunity in transplantation of rat ascitic tumors in mice].
    Novikov DK; Adamenko GP; Novikova VI
    Vopr Onkol; 1972; 18(7):77-81. PubMed ID: 4342629
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the tumor-host relationship. IV. Tumor cell agglutination with survival mouse serum.
    Tanino T; Tsumita T
    Jpn J Exp Med; 1972 Aug; 42(4):401-13. PubMed ID: 4341690
    [No Abstract]   [Full Text] [Related]  

  • 8. The isolation of normal rat liver h proteins and the immunological reactions of mouse anti-rat liver h protein.
    Louis CJ; Blunck JM
    Cancer Res; 1970 Jul; 30(7):2043-8. PubMed ID: 4318465
    [No Abstract]   [Full Text] [Related]  

  • 9. Rabbit antibodies to nucleoli of Novikoff hepatoma and normal liver of the rat.
    Busch RK; Daskal I; Spohn WH; Kellermayer M; Busch H
    Cancer Res; 1974 Sep; 34(9):2362-7. PubMed ID: 4367290
    [No Abstract]   [Full Text] [Related]  

  • 10. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of tumor rejection by trypan blue.
    Kreider JW; Bartlett GL; DeFreitas E
    Cancer Res; 1978 Apr; 38(4):1036-40. PubMed ID: 205342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theta antigen and immunogolbulin on a tissue-cultured mouse lymphoma.
    Boylston AW
    Immunology; 1973 May; 24(5):851-7. PubMed ID: 4541405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of localizing antibodies formed against microsomes of the N-2-fluorenylacetamide-induced rat hepatoma.
    Isojima S; Yagi Y; Planinsek J; Pressman D
    Cancer Res; 1965 Aug; 25(7):962-7. PubMed ID: 4284805
    [No Abstract]   [Full Text] [Related]  

  • 14. [Purification of hsp70 and its immunoprotective effect against mouse hepatoma].
    Wu W; Liu K; Gao Y
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):96-8. PubMed ID: 11776655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptors for immune complexes on cells within a non-lymphoid murine tumor.
    Braslawsky GR; Yaackubowicz M; Frensdorff A; Witz IP
    J Immunol; 1976 Jun; 116(6):1571-8. PubMed ID: 1270806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The structural-functional properties of light and dark hepatoma cells].
    Kosykh MI; Kolomina SM; Chentsov IuS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1990; (10):50-6. PubMed ID: 2177354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum factors that inhibit in vitro immunological reactions in malignant tumor development in experimental animals].
    Lomakin MS; Larin AS; Mamaeva TN; Levitina VL
    Vopr Onkol; 1977; 23(10):76-82. PubMed ID: 202095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence.
    Ihle JN; Arthur LO; Fine DL
    Cancer Res; 1976 Aug; 36(8):2840-4. PubMed ID: 179709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intensification of antineoplastic immunity with the use of chemical heterogenization of tumor tissue antigens].
    Korosteleva TA; Movsesian KS; Aleksanian IuT
    Zh Eksp Klin Med; 1974; 14(3):7-10. PubMed ID: 4370925
    [No Abstract]   [Full Text] [Related]  

  • 20. Solubilization of tumour-specific antigen from plasma membrane of an aminoazo-dye-induced rat hepatoma.
    Baldwin RW; Glaves D
    Clin Exp Immunol; 1972 May; 11(1):51-6. PubMed ID: 4338951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.